The Perspectives of Platelet Proteomics in Health and Disease
- PMID: 38540198
- PMCID: PMC10968484
- DOI: 10.3390/biomedicines12030585
The Perspectives of Platelet Proteomics in Health and Disease
Abstract
Cardiovascular thromboembolic diseases and cancer continue to be a leading cause of death and disability worldwide. Therefore, it is crucial to advance their diagnoses and treatment in the context of individualized medicine. However, the disease specificity of the currently available markers is limited. Based on analyses of a subset of peptides and matching proteins in disease vs. healthy platelets, scientists have recently shown that focused platelet proteomics enables the quantification of disease-specific biomarkers in humans. In this review, we explored the potential of accurate platelet proteomic research, which is required to identify novel diagnostic and pharmaceutical targets by comprehending the proteome variety of healthy individuals and patients for personalized and precision medicine.
Keywords: CVDs; cancer; platelet; proteomics; transfusion.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Proteomics-wise, how similar are mouse and human platelets?Platelets. 2023 Dec;34(1):2220415. doi: 10.1080/09537104.2023.2220415. Platelets. 2023. PMID: 37283127 Review.
-
Platelets in Healthy and Disease States: From Biomarkers Discovery to Drug Targets Identification by Proteomics.Int J Mol Sci. 2020 Jun 25;21(12):4541. doi: 10.3390/ijms21124541. Int J Mol Sci. 2020. PMID: 32630608 Free PMC article. Review.
-
Proteomics meets blood banking: identification of protein targets for the improvement of platelet quality.J Proteomics. 2010 Jan 3;73(3):436-44. doi: 10.1016/j.jprot.2009.08.002. Epub 2009 Aug 12. J Proteomics. 2010. PMID: 19683081 Review.
-
How can platelet proteomics best be used to interrogate disease?Platelets. 2023 Dec;34(1):2220046. doi: 10.1080/09537104.2023.2220046. Platelets. 2023. PMID: 37272536
-
Proteomics applied to the study of platelet-related diseases: aiding the discovery of novel platelet biomarkers and drug targets.J Proteomics. 2012 Dec 5;76 Spec No.:275-86. doi: 10.1016/j.jprot.2012.04.043. Epub 2012 May 8. J Proteomics. 2012. PMID: 22579745 Review.
Cited by
-
A comprehensive review of mycotoxins, their toxicity, and innovative detoxification methods.Toxicol Rep. 2025 Feb 7;14:101952. doi: 10.1016/j.toxrep.2025.101952. eCollection 2025 Jun. Toxicol Rep. 2025. PMID: 40162074 Free PMC article. Review.
-
Platelets and diseases: signal transduction and advances in targeted therapy.Signal Transduct Target Ther. 2025 May 16;10(1):159. doi: 10.1038/s41392-025-02198-8. Signal Transduct Target Ther. 2025. PMID: 40374650 Free PMC article. Review.
References
-
- Villa-Fajardo M., Palma M.C.Y., Acebes-Huerta A., Martínez-Botía P., Meinders M., Nolte M.A., Cuesta C.B., Eble J.A., Del Castillo J.G., Martín-Sánchez F.J. Platelet number and function alterations in preclinical models of sterile inflammation and sepsis patients: Implications in the pathophysiology and treatment of inflammation. Transfus. Apher. Sci. 2022;61:103413. doi: 10.1016/j.transci.2022.103413. - DOI - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources